Andrea Tan
Stock Analyst at Goldman Sachs
(1.01)
# 3,496
Out of 4,765 analysts
41
Total ratings
37.5%
Success rate
-11.23%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andrea Tan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IOVA Iovance Biotherapeutics | Maintains: Buy | $22 → $19 | $3.52 | +439.77% | 5 | Mar 3, 2025 | |
| DAWN Day One Biopharmaceuticals | Maintains: Buy | $48 → $43 | $8.70 | +394.25% | 5 | Feb 10, 2025 | |
| TARS Tarsus Pharmaceuticals | Maintains: Neutral | $36 → $41 | $46.47 | -11.77% | 3 | Nov 15, 2024 | |
| INSM Insmed | Maintains: Buy | $74 → $102 | $75.07 | +35.87% | 9 | Jul 10, 2024 | |
| SGMT Sagimet Biosciences | Maintains: Neutral | $23 → $6 | $3.51 | +70.94% | 5 | Jul 1, 2024 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Neutral | $31 | $15.07 | +105.71% | 1 | Jun 5, 2024 | |
| RLMD Relmada Therapeutics | Downgrades: Sell | $3 → $2 | $0.27 | +635.29% | 3 | Jun 5, 2024 | |
| KOD Kodiak Sciences | Reinstates: Sell | $2 | $3.45 | -42.03% | 1 | Dec 11, 2023 | |
| KRYS Krystal Biotech | Initiates: Buy | $160 | $177.37 | -9.79% | 1 | Nov 20, 2023 | |
| ABCL AbCellera Biologics | Maintains: Buy | $27 → $24 | $2.40 | +900.00% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $10 → $4 | $0.94 | +325.53% | 2 | Jan 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $178 → $375 | $323.02 | +16.09% | 1 | Dec 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $13 | $6.15 | +111.38% | 1 | Dec 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6 → $4 | $0.82 | +389.18% | 2 | May 24, 2022 |
Iovance Biotherapeutics
Mar 3, 2025
Maintains: Buy
Price Target: $22 → $19
Current: $3.52
Upside: +439.77%
Day One Biopharmaceuticals
Feb 10, 2025
Maintains: Buy
Price Target: $48 → $43
Current: $8.70
Upside: +394.25%
Tarsus Pharmaceuticals
Nov 15, 2024
Maintains: Neutral
Price Target: $36 → $41
Current: $46.47
Upside: -11.77%
Insmed
Jul 10, 2024
Maintains: Buy
Price Target: $74 → $102
Current: $75.07
Upside: +35.87%
Sagimet Biosciences
Jul 1, 2024
Maintains: Neutral
Price Target: $23 → $6
Current: $3.51
Upside: +70.94%
Arrowhead Pharmaceuticals
Jun 5, 2024
Initiates: Neutral
Price Target: $31
Current: $15.07
Upside: +105.71%
Relmada Therapeutics
Jun 5, 2024
Downgrades: Sell
Price Target: $3 → $2
Current: $0.27
Upside: +635.29%
Kodiak Sciences
Dec 11, 2023
Reinstates: Sell
Price Target: $2
Current: $3.45
Upside: -42.03%
Krystal Biotech
Nov 20, 2023
Initiates: Buy
Price Target: $160
Current: $177.37
Upside: -9.79%
AbCellera Biologics
Aug 4, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $2.40
Upside: +900.00%
Jan 9, 2023
Maintains: Sell
Price Target: $10 → $4
Current: $0.94
Upside: +325.53%
Dec 20, 2022
Maintains: Buy
Price Target: $178 → $375
Current: $323.02
Upside: +16.09%
Dec 15, 2022
Initiates: Sell
Price Target: $13
Current: $6.15
Upside: +111.38%
May 24, 2022
Maintains: Neutral
Price Target: $6 → $4
Current: $0.82
Upside: +389.18%